MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Stock
Total 13F shares
705,125
Share change
-751,535
Total reported value
$785,018
Price per share
$1.10
Number of holders
32
Value change
-$1,216,078
Number of buys
6
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q3 2023

As of 30 Sep 2023, MiNK Therapeutics, Inc. - Stock (INKT) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 705,125 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CAPTRUST FINANCIAL ADVISORS, RENAISSANCE TECHNOLOGIES LLC, ORACLE INVESTMENT MANAGEMENT INC, STATE STREET CORP, BANK OF AMERICA CORP /DE/, UBS OCONNOR LLC, and GOLDMAN SACHS GROUP INC. This page lists 32 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.